Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Minority Interest (2020 - 2022)

Historic Minority Interest for Cullinan Therapeutics (CGEM) over the last 3 years, with Q2 2022 value amounting to $80000.0.

  • Cullinan Therapeutics' Minority Interest fell 9732.53% to $80000.0 in Q2 2022 from the same period last year, while for Jun 2022 it was $80000.0, marking a year-over-year decrease of 9732.53%. This contributed to the annual value of $403000.0 for FY2021, which is 6909.51% down from last year.
  • Latest data reveals that Cullinan Therapeutics reported Minority Interest of $80000.0 as of Q2 2022, which was down 9732.53% from $768000.0 recorded in Q1 2022.
  • Cullinan Therapeutics' 5-year Minority Interest high stood at $3.0 million for Q2 2021, and its period low was $80000.0 during Q2 2022.
  • In the last 3 years, Cullinan Therapeutics' Minority Interest had a median value of $1.3 million in 2020 and averaged $1.5 million.
  • Per our database at Business Quant, Cullinan Therapeutics' Minority Interest crashed by 6909.51% in 2021 and then tumbled by 9732.53% in 2022.
  • Quarter analysis of 3 years shows Cullinan Therapeutics' Minority Interest stood at $1.3 million in 2020, then tumbled by 69.1% to $403000.0 in 2021, then crashed by 80.15% to $80000.0 in 2022.
  • Its last three reported values are $80000.0 in Q2 2022, $768000.0 for Q1 2022, and $403000.0 during Q4 2021.